KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bristol Myers Squibb (BMY) Income from Non-Controlling Interests (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Income from Non-Controlling Interests for 17 consecutive years, with -$1.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Income from Non-Controlling Interests fell 125.0% to -$1.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.0 million, a 86.67% decrease, with the full-year FY2025 number at $2.0 million, down 86.67% from a year prior.
  • Income from Non-Controlling Interests was -$1.0 million for Q4 2025 at Bristol Myers Squibb, up from -$6.0 million in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of $8.0 million in Q2 2022 to a low of -$8.0 million in Q1 2021.
  • A 5-year average of $2.3 million and a median of $4.0 million in 2023 define the central range for Income from Non-Controlling Interests.
  • Peak YoY movement for Income from Non-Controlling Interests: surged 233.33% in 2022, then tumbled 250.0% in 2025.
  • Bristol Myers Squibb's Income from Non-Controlling Interests stood at $6.0 million in 2021, then plummeted by 50.0% to $3.0 million in 2022, then surged by 100.0% to $6.0 million in 2023, then crashed by 33.33% to $4.0 million in 2024, then crashed by 125.0% to -$1.0 million in 2025.
  • Per Business Quant, the three most recent readings for BMY's Income from Non-Controlling Interests are -$1.0 million (Q4 2025), -$6.0 million (Q3 2025), and $3.0 million (Q2 2025).